Agree Moz longer study will be better in the long-term. Looking back on P2 the big moves with the SP were the interim reports showing the efficacy at each key n days. Final read out just confirmed what had been released ongoing throughout the study.
research reports and media, page-4221
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.0¢ |
Change
0.010(4.76%) |
Mkt cap ! $75.30M | |||
| Open | High | Low | Value | Volume |
| 21.0¢ | 22.0¢ | 20.5¢ | $158.1K | 738.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 82264 | 21.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 22.0¢ | 164844 | 8 |
View Market Depth
| Last trade - 14.19pm 11/10/2024 (20 minute delay) ? |
| PAR (ASX) Chart |